Presentation is loading. Please wait.

Presentation is loading. Please wait.

A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis  Kavi J. Littlewood, Kyoko Higashi,

Published byYuliani Wibowo Modified over 5 years ago

Similar presentations

Presentation on theme: "A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis  Kavi J. Littlewood, Kyoko Higashi,"— Presentation transcript:

1 A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis  Kavi J. Littlewood, Kyoko Higashi, Jeroen P. Jansen, Gorana Capkun-Niggli, Maria-Magdalena Balp, Gerd Doering, Harm A.W.M. Tiddens, Gerhild Angyalosi  Journal of Cystic Fibrosis  Volume 11, Issue 5, Pages (September 2012) DOI: /j.jcf Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

2 Fig. 1 Study selection flow diagram. *Oermann data was only available in a poster. Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

3 Fig. 2 The base case network of evidence. The network of studies that was included in the base case analysis is shown. Lines between boxes indicate which treatments were compared directly in a randomised controlled trial (RCT). Numbers in brackets reveal references. Tobramycin inhalation powder capsule (TIP), tobramycin inhalation solution 300mg/5ml (TIS-T), tobramycin inhalation solution 300mg/4ml (TIS-B), colistimethate sodium (colistin), aztreonam lysine for inhalation (AZLI). Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

4 Fig. 3 Overview of network meta-analysis scenario results for change in lung function of different antibiotics versus placebo. Exposed subgroup network did not include placebo. Fixed effects model (FEM), random effects model (REM), exposure status (EXP), forced expiratory volume (FEV), covariate (Cov), percent change from baseline (%CFB), forced expiratory volume in 1second percentage (FEV1%), tobramycin inhalation powder capsule (TIP), tobramycin inhalation solution 300mg/5ml (TIS-T), tobramycin inhalation solution 300mg/4ml (TIS-B), colistimethate sodium (colistin), aztreonam lysine for inhalation (AZLI). Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

5 Fig. 4 Overview of network meta-analysis scenario results for change in lung function of TIP versus alternative antibiotics. Fixed effects model (FEM), Random effects model (REM), exposure status (EXP), forced expiratory volume (FEV), covariate (Cov), percent change from baseline (%CFB), forced expiratory volume in 1second percentage (FEV1%), tobramycin inhalation powder capsule (TIP), tobramycin inhalation solution 300mg/5ml (TIS-T), tobramycin inhalation solution 300mg/4ml (TIS-B), colistimethate sodium (colistin), aztreonam lysine for inhalation (AZLI). Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

6 Fig. 5 Overview of network meta-analysis scenario results for change in sputum density of TIP versus alternative antibiotics. Fixed effects model (FEM), random effects model (REM), exposure status (EXP), forced expiratory volume (FEV), covariate (Cov), percent change from baseline (%CFB), forced expiratory volume in 1second percentage (FEV1%), tobramycin inhalation powder capsule (TIP), tobramycin inhalation solution 300mg/5ml (TIS-T), tobramycin inhalation solution 300mg/4ml (TIS-B), colistimethate sodium (colistin), aztreonam lysine for inhalation (AZLI). Journal of Cystic Fibrosis  , DOI: ( /j.jcf ) Copyright © 2012 European Cystic Fibrosis Society. Terms and Conditions

Download ppt "A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis  Kavi J. Littlewood, Kyoko Higashi,"

Similar presentations

Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature.

Comparison of Inhaled Antibiotics for the Treatment of Chronic Pseudomonas aeruginosa Lung Infection in Patients With Cystic Fibrosis: Systematic Literature.
Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 

Effect of dornase alfa on inflammation and lung function: Potential role in the early treatment of cystic fibrosis  Michael W. Konstan, Felix Ratjen 
Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.

Achromobacter species in cystic fibrosis: Cross-infection caused by indirect patient-to- patient contact  C.R. Hansen, T. Pressler, W. Ridderberg, H.K.
Treatment compliance in children and adults with Cystic Fibrosis

Treatment compliance in children and adults with Cystic Fibrosis
A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation.

A phase 3, multi-center, multinational, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of levofloxacin inhalation.
Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis  Mohamed Zebouh, Caroline Thomas,

Direct antimicrobial susceptibility testing method for analysis of sputum collected from patients with cystic fibrosis  Mohamed Zebouh, Caroline Thomas,
Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis,

Randomized controlled trial of biofilm antimicrobial susceptibility testing in cystic fibrosis patients  Yvonne C.W. Yau, Felix Ratjen, Elizabeth Tullis,
Felix Ratjen, Paul Koker, David E

Felix Ratjen, Paul Koker, David E
H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 

H. Grasemann, E. Tullis, F. Ratjen  Journal of Cystic Fibrosis 
A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children.

A randomized double blind, placebo controlled phase 2 trial of BIIL 284 BS (an LTB4 receptor antagonist) for the treatment of lung disease in children.
Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled.

Long-term treatment with oral N-acetylcysteine: Affects lung function but not sputum inflammation in cystic fibrosis subjects. A phase II randomized placebo-controlled.
Patrick A. Flume, John P. Clancy, George Z. Retsch-Bogart, D

Patrick A. Flume, John P. Clancy, George Z. Retsch-Bogart, D
Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,

Measures of body habitus are associated with lung function in adults with cystic fibrosis: A population-based study  Doug L. Forrester, Alan J. Knox,
Laura Viviani, Baroukh M. Assael, Eitan Kerem 

Laura Viviani, Baroukh M. Assael, Eitan Kerem 
A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.

A longitudinal analysis of chronic MRSA and Pseudomonas aeruginosa co-infection in cystic fibrosis: A single-center study  Maret L. Maliniak, Arlene A.
Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection 

Safety and efficacy of prolonged levofloxacin inhalation solution (APT-1026) treatment for cystic fibrosis and chronic Pseudomonas aeruginosa airway infection 
John Widger, Sarath Ranganathan, Philip J. Robinson 

John Widger, Sarath Ranganathan, Philip J. Robinson 
The ease of breathing test tracks clinical changes in cystic fibrosis

The ease of breathing test tracks clinical changes in cystic fibrosis
Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,

Increased serum concentration of G-CSF in cystic fibrosis patients with chronic Pseudomonas aeruginosa pneumonia  P.Ø. Jensen, C. Moser, A. Kharazmi,
Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis  Malin Carlsson, Leif Eriksson, Tania Pressler, Ragnhild Kornfält,

Autoantibody response to BPI predict disease severity and outcome in cystic fibrosis  Malin Carlsson, Leif Eriksson, Tania Pressler, Ragnhild Kornfält,

Similar presentations

Ads by Google